INFORMATION BY CANCER TYPE

Myeloma

Feature Video
Multiple Myeloma Defined
Dr Noopur Raje opens this program with a brief discussion on the basics of multiple myeloma. She describes what the disease is, highlights key risk factors, and explains how she helps educate her patients on their diagnosis. Cynthia Harrington discusses her role as a nurse practitioner when working with multiple myeloma patients and why a team-based approach between healthcare providers and the patient is important.
Moving Mountains for Multiple Myeloma: The Peak Is Just the Beginning
BY Katie Kosko
Patients with multiple myeloma climbed Mount Kilimanjaro to raise money for a cure.
Looking Ahead: What's New In CAR T-Cell Therapy for Hematologic Malignancies
BY Rebecca Bernaski
Jim Kochenderfer, M.D., lends insight to the future of CAR T-cell therapy for hematologic malignancies.
Make Multiple Myeloma Clinical Trials More Diverse
BY Lauren M. Green
It is vital to have diverse groups of patients register for clinical trials so that treatment advances can continue to be made.
Kyprolis Duo Improves Survival in Multiple Myeloma
BY Jason M. Broderick
Kyprolis (carfilzomib) plus dexamethasone improved overall survival for patients with relapsed or refractory multiple myeloma. 
Maintenance Revlimid Gains FDA Approval for Multiple Myeloma
BY Jason M. Broderick
The Food and Drug Administration (FDA) approved Revlimid (lenalidomide) for maintenance therapy for some patients with multiple myeloma.
Expert Discusses the Evolving Field of Multiple Myeloma
BY Angelica Welch
CURE spoke with Eric Smith, M.D., Ph.D. about immunotherapy and other advances being made in multiple myeloma.
Patients Living with Multiple Myeloma Will Climb Mount Kilimanjaro to Raise Funds and Awareness for Cancer Research
For the second year in a row, the Multiple Myeloma Research Foundation, Takeda and CURE Media Group will support the team of patients, family members, doctors and other participants as they trek Africa’s tallest mountain. 
 
No Increase in Skeletal-Related Events With Less Frequent Use of Zoledronic Acid
BY Ellie Leick
When zoledronic acid use happens less frequently, patients with breast cancer, prostate cancer or multiple myeloma with bone metastases did not see an increase in skeletal-related events.
MM4MM 2017 Kilimanjaro Team Training Climb
BY Moving Mountains for Multiple Myeloma
This year, a group of patients, advocates and health care professionals will tackle Mount Kilimanjaro to raise money and awareness for multiple myeloma. 

 
Special Feature
Share Your Art
Talk about this article with other patients, caregivers, and advocates in the Myeloma CURE discussion group.
Search Cancer Drugs & Terms
Treatment
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)
Expert-reviewed information summary about the treatment of plasma cell neoplasms (including multiple myeloma).
Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)
Expert-reviewed information summary about the treatment of plasma cell neoplasms (including multiple myeloma).
x